UK markets closed

Xeriant, Inc. (XERI)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0186+0.0022 (+13.41%)
At close: 03:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
79.735
0
5,268
373.112
6.376
Selling general and administrative
1,356
2,052
5,745
1,826
356.363
Total operating expenses
1,435
2,052
11,012
2,199
362.739
Operating income or loss
-1,435
-2,052
-11,012
-2,199
-362.739
Interest expense
877.894
472.408
4,768
316.427
364.981
Total other income/expenses net
-220.305
-4,573
-58.214
-186.954
28.156
Income before tax
-2,534
-7,097
-15,882
-2,703
-699.564
Income from continuing operations
-2,534
-7,097
-15,882
-2,703
-699.564
Net income
-2,503
-7,067
-13,301
-2,486
-699.564
Net income available to common shareholders
-2,503
-7,067
-13,301
-2,486
-699.564
Basic EPS
-0.01
-0.02
-0.04
-0.01
-0.01
Diluted EPS
-0.01
-0.02
-0.04
-0.01
-0.01
Basic average shares
383,150
375,099
345,160
225,497
52,426
Diluted average shares
383,150
375,099
345,160
225,497
52,426